Itolizumab provides sustained remission in plaque psoriasis: a 5‐year follow‐up experience

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2230|40|2|152-155

ISSN: 0307-6938

Source: CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol.40, Iss.2, 2015-03, pp. : 152-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract